A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This is a single-arm, single-center phase II clinical study to explore the efficacy and
safety of sintilimab combined with concurrent chemoradiation therapy as treatment in women
with locally advanced cervical cancer.
Phase:
Phase 2
Details
Lead Sponsor:
The Affiliated Hospital of Xuzhou Medical University